These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Transcatheter ViV Versus Redo Surgical AVR for the Management of Failed Biological Prosthesis: Early and Late Outcomes in a Propensity-Matched Cohort. Tam DY; Dharma C; Rocha RV; Ouzounian M; Wijeysundera HC; Austin PC; Chikwe J; Gaudino M; Fremes SE JACC Cardiovasc Interv; 2020 Mar; 13(6):765-774. PubMed ID: 31954671 [TBL] [Abstract][Full Text] [Related]
10. Coronary Angiography After Transcatheter Aortic Valve Replacement (TAVR) to Evaluate the Risk of Coronary Access Impairment After TAVR-in-TAVR. Nai Fovino L; Scotti A; Massussi M; Cardaioli F; Rodinò G; Matsuda Y; Pavei A; Masiero G; Napodano M; Fraccaro C; Fabris T; Tarantini G J Am Heart Assoc; 2020 Jul; 9(13):e016446. PubMed ID: 32578484 [TBL] [Abstract][Full Text] [Related]
11. Feasibility of Coronary Access and Aortic Valve Reintervention in Low-Risk TAVR Patients. Rogers T; Greenspun BC; Weissman G; Torguson R; Craig P; Shults C; Gordon P; Ehsan A; Wilson SR; Goncalves J; Levitt R; Hahn C; Parikh P; Bilfinger T; Butzel D; Buchanan S; Hanna N; Garrett R; Buchbinder M; Asch F; Garcia-Garcia HM; Okubagzi P; Ben-Dor I; Satler LF; Waksman R JACC Cardiovasc Interv; 2020 Mar; 13(6):726-735. PubMed ID: 32192693 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and Mid-Term Outcomes for Transcatheter Aortic Valve Replacement in Degenerated Internally Stented Valves. AlBadri A; Joseph J; Patel V; Patel D; Koren O; Cheng W; Jilaihawi H; Makkar R JACC Cardiovasc Interv; 2023 Mar; 16(5):542-554. PubMed ID: 36922040 [TBL] [Abstract][Full Text] [Related]
17. Redo procedures for degenerated stentless aortic xenografts and the role of valve-in-valve transcatheter techniques. Grubitzsch H; Zobel S; Christ T; Holinski S; Stangl K; Treskatsch S; Falk V; Laule M Eur J Cardiothorac Surg; 2017 Apr; 51(4):653-659. PubMed ID: 28062549 [TBL] [Abstract][Full Text] [Related]
18. What is the best approach in a patient with a failed aortic bioprosthetic valve: transcatheter aortic valve replacement or redo aortic valve replacement? Tourmousoglou C; Rao V; Lalos S; Dougenis D Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):837-43. PubMed ID: 25754372 [TBL] [Abstract][Full Text] [Related]
19. Transcatheter aortic valve-in-valve implantation within stentless landing zones: Procedural insights from a single-center experience. Lang FM; Mihatov N; Kriegel J; Nazif TM; Vahl TP; Ng VG; Lebehn M; Blusztein D; Cahill TJ; Lehenbauer KR; Hahn RT; Leon M; Kodali SK; George I Catheter Cardiovasc Interv; 2023 Aug; 102(2):328-338. PubMed ID: 37393603 [TBL] [Abstract][Full Text] [Related]
20. Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve-in-Valve Registry. Murdoch DJ; Sathananthan J; Hensey M; Alu MC; Liu Y; Crowley A; Wood D; Cheung A; Ye J; Feldman T; Hahn RT; Jaber WA; Mack MJ; Malaisrie SC; Leon MB; Webb JG Catheter Cardiovasc Interv; 2020 Oct; 96(4):981-986. PubMed ID: 32118351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]